Abstract

Liver fibrosis is a consequence of chronic liver injury associated with chronic viral infection, alcohol abuse, and nonalcoholic fatty liver. The evidence from clinical and animal studies indicates that transforming growth factor-β (TGF-β) signaling is associated with the development of liver fibrosis. Krüppel-like factor 10 (KLF10) is a transcription factor that plays a significant role in TGF-β-mediated cell growth, apoptosis, and differentiation. In recent studies, it has been reported to be associated with glucose homeostasis and insulin resistance. In the present study, we investigated the role of KLF10 in the progression of liver disease upon a high-sucrose diet (HSD) in mice. Wild type (WT) and Klf10 knockout (KO) mice were fed either a control chow diet or HSD (50% sucrose) for eight weeks. Klf10 KO mice exhibited significant hepatic steatosis, inflammation, and liver injury upon HSD feeding, whereas the WT mice exhibited mild hepatic steatosis with no apparent liver injury. The livers of HSD-fed Klf10 KO mice demonstrated significantly increased endoplasmic reticulum stress, oxidative stress, and proinflammatory cytokines. Klf10 deletion led to the development of sucrose-induced hepatocyte cell death both in vivo and in vitro. Moreover, it significantly increased fibrogenic gene expression and collagen accumulation in the liver. Increased liver fibrosis was accompanied by increased phosphorylation and nuclear localization of Smad3. Here, we demonstrate that HSD-fed mice develop a severe liver injury in the absence of KLF10 due to the hyperactivation of the endoplasmic reticulum stress response and CCAAT/enhance-binding protein homologous protein (CHOP)-mediated apoptosis of hepatocytes. The current study suggests that KLF10 plays a protective role against the progression of hepatic steatosis into liver fibrosis in a lipogenic state.

Highlights

  • Nonalcoholic fatty liver diseases (NAFLD), including nonalcoholic steatohepatitis (NASH), are frequent comorbidities that develop in patients with obesity, diabetes, hypertension, and dyslipidemia [1,2,3]

  • The role of Krüppel-like factor 10 (KLF10) in the development of NAFLD was evaluated in 8-week-old male Wild type (WT) and Klf 10 KO mice fed either a control chow diet (CD, 10% sucrose, 50% starch) or high-sucrose diet (HSD) (50% sucrose, 10% starch) for eight weeks

  • Klf 10 deletion activated hepatic stellate cells mediated by transforming growth factor-β (TGF-β)/Smad3 signaling, which resulted in NASH progression to fibrosis

Read more

Summary

Introduction

Nonalcoholic fatty liver diseases (NAFLD), including nonalcoholic steatohepatitis (NASH), are frequent comorbidities that develop in patients with obesity, diabetes, hypertension, and dyslipidemia [1,2,3]. When chronic damage and inflammation persist, NASH progresses to liver fibrosis, with accumulation of scar tissue in the liver, limiting the ability of the liver to function and repair itself [9,10]. This could eventually lead to cirrhosis or hepatocellular carcinoma. The excess free fatty acids in the liver cells can induce reactive oxygen species (ROS) production, which causes lipotoxic stress in the mitochondria and endoplasmic reticulum (ER) This results in mitochondrial dysfunction, ER stress, and increased apoptotic activity [14,15]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call